Peripheral Blood Mononuclear Cells Market to Grow with a CAGR of 10.39% through 2028
Increased number of cell
therapies for human well-being is expected to drive the growth of global
peripheral blood mononuclear cells market in the forecast period.
According to TechSci Research
report, “Peripheral Blood Mononuclear Cells Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, the global
peripheral blood mononuclear cells market stood at USD 235.68 million in 2022
and is anticipated to grow with a CAGR of 10.39% in the period, 2023-2028, The major factors driving the
growth of Peripheral Blood Mononuclear Cells Market include increase in number
of cell therapies, growing R&D of peripheral blood mononuclear cells and
growing usage of peripheral cells in toxicology research.
The peripheral blood mononuclear
cells (PBMCs) are used to investigate the effect of food bio-actives on various
immune cells. They have a round nucleus, consisting of macrophages, dendritic
cells, monocytes, and lymphocytes (T cells, B cells, and NK cells). However,
these cells prevent the body by developing antibodies against antigens.
However, one of the restraining
factors is ethical and legal considerations. The acquisition of PBMCs involves
obtaining blood samples from donors, which raises ethical and legal
considerations. Consent from donors, compliance with ethical guidelines, and
adherence to privacy regulations are essential. Strict regulatory frameworks
and ethical concerns can impose limitations on the collection, storage, and
utilization of PBMCs, potentially hindering the growth of global peripheral
blood mononuclear cells market. Also, the cost of PBMC isolation and processing
is high. The isolation, processing, and storage of PBMCs involve significant
costs. Specialized equipment, reagents, and skilled personnel are required for
these procedures. Moreover, maintaining optimal storage conditions, such as
low-temperature freezers, can further increase the costs.
Browse over 149 market data
figures, 14 market data tables spread through 589 Pages,
and an in-depth TOC on "Global Peripheral Blood Mononuclear Cells Market"
The global peripheral blood
mononuclear cells market is segmented into product, application, technique,
source, region, and company.
Based on product, the market is
segmented into cryopreserved or frozen PBMC, cultured or fresh PBMC, and
peripheral blood mononuclear cell isolation & viability kits. In 2022,
cryopreserved or frozen PBMC product segment held the major revenue share i.e.,
47.91%. Cryopreserved or frozen PBMCs obtained from human or animal species and
are used for long term storage. These cells can be utilized in human
immunology. Over the projected period, this segment is expected to increase at
a steady rate. The rate of increasing R&D and storage facilities leads to
the growth of this segment in PBMCs market.
Based on the application, the
market is divided into immunology, hematology, infectious disease, and others.
With a market share of 49.25% in 2022, the immunology segment is dominating the
global peripheral blood mononuclear cells market. An increase in anti-bodies
for the development of the immune system leads to the growth of market.
Based on regional analysis, in
terms of revenue share in 2022, North America dominated the global peripheral
blood mononuclear cells market by a CAGR of 10.90%. This region's expansion is
being fueled by an increasing target population and a growing number of cell
therapies. Europe accounted for the second-largest proportion, with significant
increase predicted in the future years. During the predicted period, the Asia
Pacific region is expected to grow strongly.
The leading companies operating
in the Global Peripheral Blood Mononuclear Cells Market are:
- Charles River Laboratories International, Inc.
- Lonza Group AG
- Corning Inc
- Bio-Rad Laboratories Inc
- ABCAM
- Biolegend Inc
- ZEN-Bio Inc
- DAPCEL, Inc.
- Creative Bioarray
- iXCells Biotechnologies USA, LLC
- Miltenyi Biotec B.V. & CO. KG
- STEMCELL Technologies Inc.
- Precision Medicine Group, LLC.
- StemExpress, LLC
- RayBiotech Life, Inc.
- REPROCELL Inc.
- Cytologics LLC
- BioIVT LLC
- Biopredic International
- Cell Applications, Inc.
Download Free Sample Report
Customers can also request for
10% free customization on this report.
“Global peripheral blood
mononuclear cells market will see a robust growth during the forecast period of
2024-2028. The market for peripheral blood mononuclear cells is expected to
develop due to rising research practices, cell-based therapies to either
replace or regenerate human cells, tissues, or organs for normal functioning,
and increased focus on regenerative medicine. Additionally, the global
peripheral blood mononuclear cells market has been fueled by advancements in
technology, therapies, and treatments, rising research in Biotechnology and
Cell Culture Techniques, supportive government initiatives, and funding.”, said
Mr. Karan Chechi, Research Director with TechSci Research, a research based
global management consulting firm.
“Peripheral Blood Mononuclear
Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
2018-2028, Segmented By Product
(Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, and Peripheral Blood
Mononuclear Cell Isolation & Viability Kits), By Application (Immunology,
Hematology, Infectious Disease, Hematology, and Others), By Techniques (Density
Gradient Centrifugation, Leukapheresis, and Others), By Source (Human,
Animals), By Region, Competition, Forecast and Opportunities, 2028”, has
evaluated the future growth potential of Global Peripheral Blood Mononuclear
Cells Market and provides statistics & information on market size,
structure, and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Peripheral Blood
Mononuclear Cells Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com